Bio-Rad Laboratories Inc, Hercules, Calif, recently extended its agreement with Beckman Coulter Diagnostics, Brea, Calif, by naming the company exclusive global distributor of its Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies.
John Blackwood, Beckman Coulter
The 10-year agreement extends a manufacturing and supply relationship initiated between the companies nearly 20 years ago for immunodiagnostic testing for blood viruses and infectious diseases.
“This partnership with Bio-Rad enables Beckman Coulter Diagnostics to deliver on its commitment to customers by providing a broad immunoassay menu that allows them to optimize laboratory workflow,” says John Blackwood, senior vice president of Beckman Coulter’s chemistry and immunoassay business unit. “With the new HIV combo assay and HCV assay running on the Beckman Coulter UniCel DxI and Access systems, we enable physicians to better diagnose and treat patients with blood viruses and infectious diseases.”
John Hertia, Bio-Rad
“We are pleased to extend our partnership with Beckman Coulter Diagnostics and believe the expertise of our respective organizations will add significant contributions to both HIV and hepatitis C testing laboratories and ultimately patient care,” says John Hertia, Bio-Rad executive vice president and president of the company’s clinical diagnostics group. “The strengthening of our partnership reflects each organization’s commitment in providing high value testing for these diseases.”
